- 現金殖利率: 4.15%、總殖利率: 4.15%、5年平均現金配發率: 96.22%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 1.94 | -23.62 | 2.00 | 0.0 | 0.00 | 0 | 103.09 | 30.93 | 0.00 | 0 | 103.09 | 30.93 |
2022 (9) | 2.54 | 58.75 | 2.00 | 60.0 | 0.00 | 0 | 78.74 | 0.79 | 0.00 | 0 | 78.74 | 0.79 |
2021 (8) | 1.60 | 72.04 | 1.25 | 25.0 | 0.00 | 0 | 78.12 | -27.34 | 0.00 | 0 | 78.12 | -27.34 |
2020 (7) | 0.93 | 5.68 | 1.00 | 0.0 | 0.00 | 0 | 107.53 | -5.38 | 0.00 | 0 | 107.53 | -5.38 |
2019 (6) | 0.88 | -45.68 | 1.00 | -33.33 | 0.00 | 0 | 113.64 | 22.73 | 0.00 | 0 | 113.64 | 22.73 |
2018 (5) | 1.62 | -7.95 | 1.50 | -40.0 | 0.00 | 0 | 92.59 | -34.81 | 0.00 | 0 | 92.59 | -34.81 |
2017 (4) | 1.76 | -21.43 | 2.50 | -16.67 | 0.00 | 0 | 142.05 | 6.06 | 0.00 | 0 | 142.05 | 6.06 |
2016 (3) | 2.24 | -42.42 | 3.00 | -7.69 | 0.00 | 0 | 133.93 | 60.3 | 0.00 | 0 | 133.93 | 60.3 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.63 | 425.0 | 110.0 | 0.58 | 1350.0 | 1350.0 | 0.87 | 262.5 | -26.89 |
24Q2 (19) | 0.12 | 0.0 | -83.33 | 0.04 | 120.0 | -90.91 | 0.24 | 100.0 | -73.03 |
24Q1 (18) | 0.12 | -84.21 | -25.0 | -0.20 | -118.35 | -183.33 | 0.12 | -93.85 | -25.0 |
23Q4 (17) | 0.76 | 153.33 | -55.29 | 1.09 | 2625.0 | -44.39 | 1.95 | 63.87 | -23.53 |
23Q3 (16) | 0.30 | -58.33 | -38.78 | 0.04 | -90.91 | -77.78 | 1.19 | 33.71 | 40.0 |
23Q2 (15) | 0.72 | 350.0 | 227.27 | 0.44 | 83.33 | 0 | 0.89 | 456.25 | 147.22 |
23Q1 (14) | 0.16 | -90.59 | 14.29 | 0.24 | -87.76 | 700.0 | 0.16 | -93.73 | 14.29 |
22Q4 (13) | 1.70 | 246.94 | 65.05 | 1.96 | 988.89 | 88.46 | 2.55 | 200.0 | 59.37 |
22Q3 (12) | 0.49 | 122.73 | 58.06 | 0.18 | 0 | -10.0 | 0.85 | 136.11 | 49.12 |
22Q2 (11) | 0.22 | 57.14 | 46.67 | 0.00 | 100.0 | -100.0 | 0.36 | 157.14 | 38.46 |
22Q1 (10) | 0.14 | -86.41 | 27.27 | -0.04 | -103.85 | -200.0 | 0.14 | -91.25 | 27.27 |
21Q4 (9) | 1.03 | 232.26 | 312.0 | 1.04 | 420.0 | 372.73 | 1.60 | 180.7 | 72.04 |
21Q3 (8) | 0.31 | 106.67 | 158.33 | 0.20 | 53.85 | 53.85 | 0.57 | 119.23 | -16.18 |
21Q2 (7) | 0.15 | 36.36 | -68.75 | 0.13 | 225.0 | -72.34 | 0.26 | 136.36 | -53.57 |
21Q1 (6) | 0.11 | -56.0 | 37.5 | 0.04 | -81.82 | 200.0 | 0.11 | -88.17 | 37.5 |
20Q4 (5) | 0.25 | 108.33 | 127.27 | 0.22 | 69.23 | -18.52 | 0.93 | 36.76 | 5.68 |
20Q3 (4) | 0.12 | -75.0 | 0.0 | 0.13 | -72.34 | 0.0 | 0.68 | 21.43 | 0.0 |
20Q2 (3) | 0.48 | 500.0 | 0.0 | 0.47 | 1275.0 | 0.0 | 0.56 | 600.0 | 0.0 |
20Q1 (2) | 0.08 | -27.27 | 0.0 | -0.04 | -114.81 | 0.0 | 0.08 | -90.91 | 0.0 |
19Q4 (1) | 0.11 | 0.0 | 0.0 | 0.27 | 0.0 | 0.0 | 0.88 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 2.78 | 13.86 | 14.05 | 23.47 | 5.74 | 7.46 | N/A | - | ||
2024/9 | 2.44 | 9.35 | 21.76 | 20.68 | 4.72 | 7.56 | 1.89 | - | ||
2024/8 | 2.24 | -22.33 | -3.99 | 18.24 | 2.79 | 7.59 | 1.88 | - | ||
2024/7 | 2.88 | 16.19 | 62.25 | 16.0 | 3.81 | 7.79 | 1.83 | 專案收入認列與海外營收均較去年同期增長 | ||
2024/6 | 2.48 | 1.78 | 16.8 | 13.12 | -3.78 | 7.12 | 1.91 | - | ||
2024/5 | 2.43 | 10.15 | 7.46 | 10.65 | -7.57 | 6.67 | 2.04 | - | ||
2024/4 | 2.21 | 9.25 | -11.96 | 8.21 | -11.25 | 5.95 | 2.29 | - | ||
2024/3 | 2.02 | 17.85 | 5.83 | 6.0 | -10.98 | 6.0 | 2.15 | - | ||
2024/2 | 1.72 | -24.22 | -20.86 | 3.98 | -17.63 | 7.09 | 1.82 | - | ||
2024/1 | 2.26 | -27.09 | -15.0 | 2.26 | -15.0 | 9.33 | 1.39 | - | ||
2023/12 | 3.11 | -21.46 | -10.9 | 29.25 | -4.33 | 9.5 | 1.32 | - | ||
2023/11 | 3.96 | 62.05 | -30.93 | 26.15 | -3.49 | 8.4 | 1.49 | - | ||
2023/10 | 2.44 | 21.56 | 9.94 | 22.19 | 3.86 | 6.78 | 1.85 | - | ||
2023/9 | 2.01 | -13.77 | -20.68 | 19.75 | 3.16 | 6.11 | 2.37 | - | ||
2023/8 | 2.33 | 31.24 | -3.23 | 17.74 | 6.79 | 6.22 | 2.33 | - | ||
2023/7 | 1.77 | -16.35 | -20.96 | 15.41 | 8.49 | 6.16 | 2.35 | - | ||
2023/6 | 2.12 | -6.35 | 4.17 | 13.64 | 14.02 | 6.9 | 1.98 | - | ||
2023/5 | 2.26 | -9.76 | 36.36 | 11.52 | 16.04 | 6.69 | 2.04 | - | ||
2023/4 | 2.51 | 31.35 | 52.45 | 9.25 | 11.95 | 6.59 | 2.07 | 本月營收增加主要來自本月專案認列營收較去年同期成長及海外市場開拓成效顯現 | ||
2023/3 | 1.91 | -11.88 | -8.59 | 6.74 | 1.88 | 6.74 | 2.12 | - | ||
2023/2 | 2.17 | -18.6 | 13.31 | 4.83 | 6.72 | 8.32 | 1.72 | - | ||
2023/1 | 2.66 | -23.57 | 1.89 | 2.66 | 1.89 | 11.88 | 1.2 | - | ||
2022/12 | 3.49 | -39.12 | -38.69 | 30.58 | 2.46 | 11.43 | 1.3 | - | ||
2022/11 | 5.73 | 157.98 | 124.36 | 27.09 | 12.15 | 10.48 | 1.42 | 本月有大型專案完工驗收認列營收 | ||
2022/10 | 2.22 | -12.29 | 17.18 | 21.36 | -1.1 | 7.16 | 2.08 | - | ||
2022/9 | 2.53 | 5.19 | 15.26 | 19.14 | -2.86 | 7.18 | 2.41 | - | ||
2022/8 | 2.41 | 7.19 | 15.61 | 16.61 | -5.13 | 6.69 | 2.59 | - | ||
2022/7 | 2.24 | 10.25 | -0.6 | 14.21 | -7.93 | 5.94 | 2.92 | - | ||
2022/6 | 2.04 | 22.58 | -11.26 | 11.96 | -9.19 | 5.34 | 2.99 | - | ||
2022/5 | 1.66 | 0.88 | -25.34 | 9.93 | -8.75 | 5.4 | 2.96 | - | ||
2022/4 | 1.65 | -21.24 | -29.88 | 8.27 | -4.49 | 5.65 | 2.82 | - | ||
2022/3 | 2.09 | 9.23 | -8.66 | 6.62 | 4.96 | 6.62 | 2.02 | - | ||
2022/2 | 1.91 | -26.8 | -0.02 | 4.53 | 12.72 | 10.22 | 1.31 | - | ||
2022/1 | 2.61 | -54.01 | 24.32 | 2.61 | 24.32 | 10.85 | 1.23 | - | ||
2021/12 | 5.69 | 122.78 | 124.85 | 29.84 | 26.34 | 10.13 | 1.18 | 本月有大型專案完工驗收認列營收 | ||
2021/11 | 2.55 | 34.74 | 13.06 | 24.16 | 14.53 | 6.64 | 1.8 | - | ||
2021/10 | 1.89 | -13.73 | 0.58 | 21.6 | 14.71 | 6.17 | 1.94 | - | ||
2021/9 | 2.2 | 5.5 | 8.0 | 19.71 | 16.28 | 6.54 | 2.08 | - | ||
2021/8 | 2.08 | -7.83 | 8.2 | 17.51 | 17.4 | 6.63 | 2.05 | - | ||
2021/7 | 2.26 | -1.56 | 9.76 | 15.43 | 18.77 | 6.78 | 2.01 | - | ||
2021/6 | 2.29 | 3.12 | 18.22 | 13.17 | 20.46 | 6.87 | 1.86 | - | ||
2021/5 | 2.22 | -5.24 | 11.75 | 10.88 | 20.94 | 6.86 | 1.87 | - | ||
2021/4 | 2.35 | 2.58 | 35.35 | 8.65 | 23.56 | 6.55 | 1.95 | - | ||
2021/3 | 2.29 | 19.57 | 11.4 | 6.31 | 19.67 | 6.31 | 1.86 | - | ||
2021/2 | 1.91 | -8.98 | 50.69 | 4.02 | 24.96 | 6.55 | 1.8 | 去年受新冠病毒疫情影響,大陸工廠復工延遲,致基期營收低於正常水準 | ||
2021/1 | 2.1 | -16.83 | 8.16 | 2.1 | 8.16 | 6.89 | 1.71 | - | ||
2020/12 | 2.53 | 12.02 | -4.93 | 23.62 | -4.88 | 6.67 | 1.68 | - | ||
2020/11 | 2.26 | 19.87 | 25.29 | 21.09 | -4.87 | 6.17 | 1.81 | - | ||
2020/10 | 1.88 | -7.37 | 1.31 | 18.83 | -7.54 | 5.84 | 1.92 | - | ||
2020/9 | 2.03 | 5.7 | 9.02 | 16.95 | -8.43 | 6.01 | 1.83 | - | ||
2020/8 | 1.92 | -6.51 | -10.41 | 14.92 | -10.39 | 5.92 | 1.86 | - | ||
2020/7 | 2.06 | 6.02 | -33.37 | 12.99 | -10.38 | 5.99 | 1.84 | - | ||
2020/6 | 1.94 | -2.52 | -6.71 | 10.94 | -4.16 | 5.67 | 1.94 | - | ||
2020/5 | 1.99 | 14.75 | -4.72 | 8.99 | -3.59 | 5.78 | 1.9 | - | ||
2020/4 | 1.73 | -15.56 | -12.8 | 7.0 | -3.27 | 5.06 | 2.18 | - | ||
2020/3 | 2.05 | 61.74 | 8.16 | 5.27 | 0.34 | 5.27 | 1.82 | - | ||
2020/2 | 1.27 | -34.67 | -24.13 | 3.21 | -4.09 | 5.88 | 1.63 | - | ||
2020/1 | 1.94 | -26.91 | 15.9 | 1.94 | 15.9 | 6.41 | 1.5 | - | ||
2019/12 | 2.66 | 47.65 | -3.69 | 24.83 | -1.87 | 0.0 | N/A | - | ||
2019/11 | 1.8 | -3.07 | 2.36 | 22.17 | -1.65 | 0.0 | N/A | - |